Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
30 hedge funds and large institutions have $7.6M invested in Vaxxinity, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 29 → 30 (+1)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
84% less capital invested
Capital invested by funds: $48.5M → $7.6M (-$40.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$94.5K |
| 2 |
State Street
Boston,
Massachusetts
|
+$91.9K |
| 3 |
Bank of New York Mellon
New York
|
+$58.5K |
| 4 |
VF
Virtu Financial
New York
|
+$30K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PML
Prime Movers Lab
Jackson,
Wyoming
|
-$31.4M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.45M |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$394K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$352K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$198K |
VAXX Hedge Fund Activity: Q4 2022 in Review
30 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q4 2022, worth a combined $7.6M — down 84% from $48.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VAXX positions and 7 closed out — a net gain of 1 holder — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Millennium Management, adding an estimated $94.5K. The largest seller was Prime Movers Lab, exiting entirely with an estimated $31.4M sold.
- 30 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q4 2022, up from 29 in Q3 2022.
- Funds reported $7.6M of Vaxxinity, Inc. Class A Common Stock stock for Q4 2022, down 84% quarter-over-quarter.
- 8 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +1 holder.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q4 2022 was Millennium Management, an estimated $94.5K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q4 2022 was Prime Movers Lab, an estimated $31.4M sold.
Based on aggregated 13F filings for Q4 2022.